CYP19A1 and breast cancer: In particular, LEP has been demonstrated to enhance aromatase expression in MCF-7 breast cancer cells [40], and to be strictly involved in estrogen receptor (ER) activity modulation, through the existing crosstalk between LEP and ERα [41].